Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Circulating microRNA-133a in Patients With Arterial Hypertension, Hypertensive Heart Disease, and Left Ventricular Diastolic Dysfunction
The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism | Scientific Reports
JCM | Free Full-Text | Clinical Application of Serum microRNAs in Atherosclerotic Coronary Artery Disease
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
Biomolecules | Free Full-Text | Deregulation of Plasma microRNA Expression in a TARDBP-ALS Family
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
IJMS | Free Full-Text | Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far
Plasma MicroRNA-133a as a Potential Biomarker for Acute Coronary Syndrome
MicroRNAs as Potential Predictors of Postoperative AF | ECR Journal
Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction | Clinics
PDF) Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis
Frontiers | MicroRNAs as Biomarkers for Animal Health and Welfare in Livestock
Time course of microRNAs plasma levels and troponin I in mice with... | Download Scientific Diagram
Ultrasensitive and Simultaneous SERS Detection of Multiplex MicroRNA Using Fractal Gold Nanotags for Early Diagnosis and Prognosis of Hepatocellular Carcinoma | Analytical Chemistry
microRNA‐based diagnostic and therapeutic applications in cancer medicine - Sempere - 2021 - WIREs RNA - Wiley Online Library
Emerging roles of MiR-133a in human cancers
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 | Scientific Reports
Frontiers | Circulating MicroRNAs: Biogenesis and Clinical Significance in Acute Myocardial Infarction
Life | Free Full-Text | Current Knowledge of MicroRNAs (miRNAs) in Acute Coronary Syndrome (ACS): ST-Elevation Myocardial Infarction (STEMI)
Diagnostics | Free Full-Text | MicroRNAs as Biomarkers of Systemic Changes in Response to Endurance Exercise—A Comprehensive Review
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
Frontiers | miR-133: A Suppressor of Cardiac Remodeling?
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis | Journal of Translational Medicine | Full Text
MicroRNAs and Myocardial Infarct: Investigating the Controversial Role of Second Generation Biomarkers. | Semantic Scholar
MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets - ScienceDirect
Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy | Scientific Reports
